Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 564940, 6 pages
http://dx.doi.org/10.1155/2014/564940
Research Article

Meta-Analysis of Low Density Lipoprotein Receptor (LDLR) rs2228671 Polymorphism and Coronary Heart Disease

1Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, China
2The Affiliated Hospital, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, China
3Yinzhou People’s Hospital, School of Medicine, Ningbo University, Ningbo, Zhejiang 315040, China
4Bank of Blood Products, Ningbo No. 2 Hospital, Ningbo, Zhejiang 315010, China

Received 29 January 2014; Revised 3 April 2014; Accepted 22 April 2014; Published 12 May 2014

Academic Editor: Hongwei Wang

Copyright © 2014 Huadan Ye et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. A. Phillips, A. T. Cote, S. S. Bredin, and D. E. Warburton, “Heart disease and left ventricular rotation—a systematic review and quantitative summary,” BMC Cardiovascular Disorders, vol. 12, article 46, 2012. View at Google Scholar
  2. M. S. Brown and J. L. Goldstein, “Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man,” Science, vol. 185, no. 4145, pp. 61–63, 1974. View at Google Scholar · View at Scopus
  3. I. Ejarque, J. T. Real, S. Martinez-Hervas et al., “Evaluation of clinical diagnosis criteria of familial ligand defective apoB 100 and lipoprotein phenotype comparison between LDL receptor gene mutations affecting ligand-binding domain and the R3500Q mutation of the apoB gene in patients from a South European population,” Translational Research, vol. 151, no. 3, pp. 162–167, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. E. W. Lee, M. Michalkiewicz, J. Kitlinska et al., “Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles,” Journal of Clinical Investigation, vol. 111, no. 12, pp. 1853–1862, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Zhou, Y. Huang, R. S. Huang et al., “A case-control study provides evidence of association for a common SNP rs974819 in PDGFD to coronary heart disease and suggests a sex-dependent effect,” Thrombosis Research, vol. 130, pp. 602–606, 2012. View at Google Scholar
  6. R. Bulbulia and J. Armitage, “LDL cholesterol targets—how low to go?” Current Opinion in Lipidology, vol. 23, pp. 265–270, 2012. View at Google Scholar
  7. R. Alonso, N. Mata, S. Castillo et al., “Cardiovascular disease in familial hypercholesterolaemia: Influence of low-density lipoprotein receptor mutation type and classic risk factors,” Atherosclerosis, vol. 200, no. 2, pp. 315–321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Kathiresan, C. J. Willer, G. M. Peloso et al., “Common variants at 30 loci contribute to polygenic dyslipidemia,” Nature Genetics, vol. 41, no. 1, pp. 56–65, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Kathiresan, B. F. Voight, S. Purcell et al., “Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants,” Nature Genetics, vol. 41, no. 3, pp. 334–341, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Linsel-Nitschke, A. Götz, J. Erdmann et al., “Lifelong reduction of LDL-cholesterol related to a common varriant in the LDL-receptor gene decreases the risk of coronary artery disease—a Mendelian randomisation study,” PLoS ONE, vol. 3, no. 8, Article ID e2986, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. R. Ortlepp, A. Von Korff, P. Hanrath, K. Zerres, and R. Hoffmann, “Vitamin D receptor gene polymorphism BsmI is not associated with the prevalence and severity of CAD in a large-scale angiographic cohort of 3441 patients,” European Journal of Clinical Investigation, vol. 33, no. 2, pp. 106–109, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Krawczak, S. Nikolaus, H. Von Eberstein, P. J. Croucher, N. E. El Mokhtari, and S. Schreiber, “PopGen: Population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships,” Community Genetics, vol. 9, no. 1, pp. 55–61, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. N. J. Samani, J. Erdmann, A. S. Hall et al., “Genomewide association analysis of coronary artery disease,” New England Journal of Medicine, vol. 357, no. 5, pp. 443–453, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Schunkert, A. Götz, P. Braund et al., “Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease,” Circulation, vol. 117, no. 13, pp. 1675–1684, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Erdmann, A. Großhennig, P. S. Braund et al., “New susceptibility locus for coronary artery disease on chromosome 3q22.3,” Nature Genetics, vol. 41, no. 3, pp. 280–282, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Martinelli, D. Girelli, B. Lunghi et al., “Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile,” Blood, vol. 116, no. 25, pp. 5688–5697, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Cassese, A. de Waha, G. Ndrepepa et al., “Intra-aortic balloon counterpulsation in patients with acute myocardial infarction without cardiogenic shock. A meta-analysis of randomized trials,” American Heart Journal, vol. 164, article e51, pp. 58–65, 2012. View at Google Scholar
  18. C. Wang, T. Sun, H. Li, J. Bai, and Y. Li, “Lipoprotein lipase Ser447Ter polymorphism associated with the risk of ischemic stroke: a meta-analysis,” Thrombosis Research, vol. 128, no. 5, pp. e107–e112, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Rapaport, R. Bernard, and E. Corday, “Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on standardization of clinical nomenclature,” Circulation, vol. 59, no. 3, pp. 607–609, 1979. View at Google Scholar · View at Scopus
  20. L. Excoffier and H. E. L. Lischer, “Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows,” Molecular Ecology Resources, vol. 10, no. 3, pp. 564–567, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. P. C. Sham and D. Curtis, “Monte Carlo tests for associations between disease and alleles at highly polymorphic loci,” Annals of Human Genetics, vol. 59, no. 1, pp. 97–105, 1995. View at Google Scholar · View at Scopus
  22. W. D. Dupont and W. D. Plummer Jr., “Power and sample size calculations. A review and computer program,” Controlled Clinical Trials, vol. 11, no. 2, pp. 116–128, 1990. View at Publisher · View at Google Scholar · View at Scopus
  23. D. F. Stroup, J. A. Berlin, S. C. Morton et al., “Meta-analysis of observational studies in epidemiology: a proposal for reporting,” Journal of the American Medical Association, vol. 283, no. 15, pp. 2008–2012, 2000. View at Google Scholar · View at Scopus
  24. J. W. Bisson and V. J. Cabelli, “Membrane filter enumeration method for Clostridium perfringens,” Applied and Environmental Microbiology, vol. 37, no. 1, pp. 55–66, 1979. View at Google Scholar · View at Scopus
  25. M. Egger, G. Davey Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” British Medical Journal, vol. 315, pp. 629–634, 1997. View at Google Scholar
  26. R. DerSimonian and N. Laird, “Meta-analysis in clinical trials,” Controlled Clinical Trials, vol. 7, no. 3, pp. 177–188, 1986. View at Google Scholar · View at Scopus
  27. S. Kathiresan, O. Melander, C. Guiducci et al., “Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans,” Nature Genetics, vol. 40, no. 11, pp. 189–197, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. S. H. Wu, Y. Q. Wang, and D. Q. Sun, “The association of HincII/low density lipoprotein receptor (LDLR) restriction fragment length polymorphism (RFLP) with diabetes mellitus and its lipid phenotype with PCR gene amplification,” Zhonghua Yi Xue Za Zhi, vol. 73, no. 1, pp. 10–60, 1993. View at Google Scholar · View at Scopus
  29. Y. Yamada, K. Kato, T. Yoshida et al., “Association of polymorphisms of ABCA1 and ROS1 with hypertension in Japanese individuals,” International Journal of Molecular Medicine, vol. 21, no. 1, pp. 83–89, 2008. View at Google Scholar · View at Scopus
  30. J. M. Murabito, C. C. White, M. Kavousi et al., “Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies,” Circulation Cardiovascular Genetics, vol. 5, pp. 100–112, 2012. View at Google Scholar
  31. W. Chen, S. Wang, Y. Ma et al., “Analysis of polymorphisms in the 3′ untranslated region of the LDL receptor gene and their effect on plasma cholesterol levels and drug response,” International Journal of Molecular Medicine, vol. 21, no. 3, pp. 345–353, 2008. View at Google Scholar · View at Scopus
  32. E. Polisecki, H. Muallem, N. Maeda et al., “Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER,” Atherosclerosis, vol. 200, no. 1, pp. 109–114, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Takeuchi, M. Isono, T. Katsuya et al., “Association of genetic variants influencing lipid levels with coronary artery disease in Japanese individuals,” PLoS ONE, vol. 7, Article ID e46385, 2012. View at Google Scholar
  34. P. Jeemon, K. Pettigrew, C. Sainsbury, D. Prabhakaran, and S. Padmanabhan, “Implications of discoveries from genome-wide association studies in current cardiovascular practice,” World Journal of Cardiology, vol. 3, pp. 230–247, 2011. View at Google Scholar
  35. L. Zhang, F. Yuan, P. Liu et al., “Association between PCSK9 and LDLR gene polymorphisms with coronary heart disease: case-control study and meta-analysis,” Clinical Biochemistry, vol. 46, pp. 727–732, 2013. View at Google Scholar